ASHP Midyear Clinical Meeting & Exhibition

A discussion with Brittany Norton, PharmD, director of ambulatory care at Sutter Health.

Navigating Cannabis use requires more than just an understanding of the endocannabinoid system.

Two posters presented at ASHP Midyear 2023 explored the impact of diabetes management interventions among patients with diabetes.

Three posters presented at ASHP Midyear 2023 delved deeper into the topic of antimicrobial stewardship programs and their impact on antibiotic resistance.

Two posters presented at ASHP Midyear 2023 looked at how the two medications differed and how clinical pharmacy services improved transitions.

The analysis revealed deeper issues created by payer and manufacturer lockouts placed on Integrated Health System Specialty Pharmacies.

Two posters presented at ASHP 2023 Midyear examined how accurate answers were from the artificial intelligence chatbot.

Investigators developed a new Plan-Do-Study-Act cycle to meet standards of USP <800> at a central-fill pharmacy.

A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.

Increased clinical awareness around the value of lithium monitoring was ultimately achieved.

A study presented at ASHP Midyear 2023 found that primary care physicians said a refill management service helped reduce burnout and improved the quality of patient care.

A Q&A with Lisa McCabe, PharmD, MBA, BSN, director of Health System Pharmacy at Cardinal Health.

Most patients were not concerned about losing control over their disease after switching.

Study results outlined in a poster at ASHP Midyear 2023 revealed that virtual delivery education programs could contribute to a more inclusive and accessible health care information landscape for Black older adults.

These populations are also more likely to receive opioid analgesic therapies.

The CDC first released opioid prescribing guidelines in 2016.

Updated guidance from the United States Preventive Services Task Force advises against low-dose aspirin use as a primary prevention of atherosclerotic cardiovascular disease in certain populations who have bleeding risks.

A poster presented at ASHP Midyear 2023 highlighted the positive impact of including pharmacists in the care of postpartum women at risk of persistently elevated blood pressure (BP), particularly in cases of portopulmonary hypertension (PPHTN).

According to a poster abstract presented at the ASHP Midyear Clinical Meeting & Exhibition, specialty pharmacy services were used for a variety of conditions that have been reported in adult populations.

A poster from ASHP Midyear 2023 demonstrated the effectiveness of liposomal bupivacaine as it is used for cesarean section procedures, regarded as an area with increasing utilization.

According to a poster presented at ASHP Midyear 2023, stress ulcer prophylaxis (SUP) did not increase adverse effects, suggesting limited preventive benefits for gastrointestinal bleeding (GIB) in neonates.

Three poster presented at the ASHP Midyear Clinical Meeting delved deeper into perioperative pain management.

An evaluative study on an open resource Instagram page that provides information on new medications to pharmacists was recently presented at the American Society of Health-System Pharmacists 2023 Midyear Clinical Meeting and Exhibition.

When dealing with marginalized and underserved populations, it is important to understand barriers to care and why they exist.

With increasing use of telehealth, patients need access to resources that let them get the most out of the experience.

Social support and education may be the solution.

A group of pharmacists rose to the occasion to help a man having a medical emergency aboard a recent United flight bound for Newark, New Jersey.

The U.S. biosimilar landscape is changing, and legislation may be the key to controlling drug prices and advancing the market.

Cost savings were not associated with an increase in adverse drug events.

Knowledge gaps can make OTC medication recommendations for this population a challenge.